The goal of this clinical trial is to study the effects of stellate ganglion block (SGB) in participants with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The main questions it aims to answer are: Does SGB treatment improve symptoms of ME/CFS (e.g. brain fog, fatigue)? Do changes in symptoms go along with changes in blood or saliva? Participants will receive a total of six blocks over three weeks (one block on each side, one day apart, per week). Prior to treatment and at two points following treatment, participants will complete surveys, take a cognitive (puzzle type) test, and provide blood and saliva for analysis. Participants will measure their heart rate daily using a free smart phone app.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Subjective Rating of Symptoms at 2 Weeks
Timeframe: 2 weeks
Change in Subjective Rating of Symptoms at 2 Months
Timeframe: 2 months
Change in Cognitive Function at 2 Weeks
Timeframe: 2 weeks
Change in Cognitive Function at 2 Months
Timeframe: 2 months